Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Zorginstituut adviseert cannabidiol te vergoeden voor kinderen met ernstige epilepsie
jul 2022 | Epilepsie